Sivanandhan Dhanalakshmi

Author

Also Known As

DHANALAKSHMI SIVANANDHAN, Dhanalakshmi S, Dhanalakshmi Sivanandhan, S Dhanalakshmi, S. Dhanalakshmi, Sivanandhan Dhanalakshmi, Sivanandhan K

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Health University of Colorado Cancer Center University of Colorado Denver Pharmaceutical Biotechnology (Czechia)University of Colorado Anschutz Medical Campus

About

Sivanandhan Dhanalakshmi is an author at University of Colorado Health specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.2K
2	Cell Biology	6	6	517
3	Public Health	1	1	110
4	Immunology	1	1	131
5	Nutrition	1	1	192

Sivanandhan Dhanalakshmi

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells Chapla Agarwal, Rana P. Singh, Sivanandhan Dhanalakshmi, Oncogene Cyclin-dependent Kinase InhibitorsOncologyMedicineCycle ArrestCell Death	2003	223
Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels. Rana P. Singh, Sivanandhan Dhanalakshmi, Anil K. Tyagi, PubMed NutritionDietary FeedingHuman GrowthPathologyTumor Biology	2002	192
Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin‐like growth factor binding protein‐3 Rana P. Singh, Akhilesh K. Tyagi, Sivanandhan Dhanalakshmi, International Journal of Cancer	2003	183
Phytochemicals as Cell Cycle Modulators A Less Toxic Approach in Halting Human Cancers Rana P. Singh, Sivanandhan Dhanalakshmi, Rajesh Agarwal Cell Cycle	2002	173
Silibinin inhibits constitutive and TNFα-induced activation of NF-κB and sensitizes human prostate carcinoma DU145 cells to TNFα-induced apoptosis Sivanandhan Dhanalakshmi, Rana P. Singh, Chapla Agarwal, Oncogene Tumor BiologyTnfα-induced ApoptosisOncologyMedicinePharmacology	2002	155
Silibinin Protects against Photocarcinogenesis via Modulation of Cell Cycle Regulators, Mitogen-Activated Protein Kinases, and Akt Signaling Mallikarjuna Gu, Sivanandhan Dhanalakshmi, Rana P. Singh, Cancer Research	2004	147
Silibinin Inhibits Inflammatory and Angiogenic Attributes in Photocarcinogenesis in SKH-1 Hairless Mice Mallikarjuna Gu, Rana P. Singh, Sivanandhan Dhanalakshmi, Cancer Research	2007	146
Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-κB: implications for angioprevention and antiangiogenic therapy Rana P. Singh, Sivanandhan Dhanalakshmi, Chapla Agarwal, Oncogene AngiogenesisChemoprevention StrategyMedicineEndothelial DysfunctionCell Cycle Arrest	2004	139
Oral Silibinin Inhibits Lung Tumor Growth in Athymic Nude Mice and Forms a Novel Chemocombination with Doxorubicin Targeting Nuclear Factor κB–Mediated Inducible Chemoresistance Rana P. Singh, G. U. Mallikarjuna, Girish Sharma, Clinical Cancer Research ImmunologyPathologyPharmacotherapyTumor BiologyDrug Resistance	2004	131
Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis. Rana P. Singh, Girish Sharma, Sivanandhan Dhanalakshmi, PubMed Control GroupUrologySilibinin FeedingChemoprevention StrategyOncogenic Agent	2003	125

Page 1